Yan Li

机构：The University of Sydney, Guiyang Medical University, Bristol-Myers Squibb (Germany), Sun Yat-sen University, Shenzhen University, Shandong Normal University, State Intellectual Property Office, Ruijin Hospital, Bristol-Myers Squibb (United States), Sun Yat-sen Memorial Hospital, 117th Hospital of People's Liberation Army, Ningxia Medical University, Shanghai Institute of Hypertension, Bristol-Myers Squibb (Sweden), Ningxia Medical University General Hospital, Tianjin Hospital, Shenzhen University Health Science Center, Central Hospital of Zibo, State Key Laboratory of Medical Genomics · ORCID：0000-0001-7609-2683

发表论文 164 篇 · 总被引 1877 次 · h-index 23

代表论文

• Antiepileptic Drug Combinations for Epilepsy: Mechanisms, Clinical Strategies, and Future Prospects (2025 · International Journal of Molecular Sciences · 被引 32)
• Life’s Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China (2025 · Cardiovascular Diabetology · 被引 21)
• Progress in the application of isothermal amplification technology in the diagnosis of infectious diseases (2025 · Frontiers in Microbiology · 被引 19)
• Probiotics Attenuate Food Allergy via Short-Chain Fatty Acids-Mediated Immune Modulation and Gut Barrier Restoration (2025 · Foods · 被引 7)
• Obesity mediates the association between psoriasis and diabetes incidence: a population-based study (2025 · Diabetology & Metabolic Syndrome · 被引 7)
• Enhancing pharmacometric modeling with full Bayesian inference and Student’s t-Based M3 Censoring: A simulated population PK study on robust handling of outliers and censored data (2025 · Journal of Pharmaceutical Sciences · 被引 6)